NCT04301284: A trial that was reported late by Cadent Therapeutics
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04301284 |
|---|---|
| Title | Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of CAD-1883 in Adults With Spinocerebellar Ataxia (Synchrony-1) |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 30, 2021 |
| Completion date | Nov. 30, 2022 |
| Required reporting date | Nov. 30, 2023, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 9, 2021 |
| Days late | None |